Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-11 7:30 pm Sale |
2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
BIOTECHNOLOGY VALUE FUND L P | 1,370,947 3.000% |
-1,527,850![]() (-52.71%) |
Filing History |
2022-02-11 7:22 pm Sale |
2021-12-31 | 13G | Merus N.V. MRUS |
BIOTECHNOLOGY VALUE FUND L P | 4,135,071 9.600% |
-925,000![]() (-18.28%) |
Filing History |
2022-01-31 5:07 pm Purchase |
2022-01-27 | 13D | Kymera Therapeutics, Inc. KYMR |
BIOTECHNOLOGY VALUE FUND L P | 3,586,658 7.000% |
955,996![]() (+36.34%) |
Filing History |
2022-01-28 4:35 pm Purchase |
2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 2,326,710 16.900% |
878,690![]() (+60.68%) |
Filing History |
2022-01-24 5:23 pm Purchase |
2022-01-13 | 13G | Aclaris Therapeutics, Inc. ACRS |
BIOTECHNOLOGY VALUE FUND L P | 3,868,043 6.300% |
3,868,043![]() (New Position) |
Filing History |
2022-01-18 5:18 pm Purchase |
2022-01-07 | 13G | Sutro Biopharma, Inc. STRO |
BIOTECHNOLOGY VALUE FUND L P | 3,160,416 6.800% |
1,306,254![]() (+70.45%) |
Filing History |
2022-01-12 5:05 pm Purchase |
2022-01-10 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 4,526,282 14.100% |
1,425,000![]() (+45.95%) |
Filing History |
2022-01-12 5:03 pm Purchase |
2021-12-31 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 3,101,282 9.700% |
602,381![]() (+24.11%) |
Filing History |
2022-01-11 5:13 pm Purchase |
2022-01-07 | 13D | Rain Enhancement Technologies Holdco Inc RAIN |
BIOTECHNOLOGY VALUE FUND L P | 3,526,729 18.800% |
580,922![]() (+19.72%) |
Filing History |
2022-01-10 5:57 pm Purchase |
2022-01-06 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 1,448,020 10.100% |
13,088![]() (+0.91%) |
Filing History |
2022-01-10 5:51 pm Purchase |
2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 1,434,932 9.990% |
1,434,932![]() (New Position) |
Filing History |
2022-01-10 4:52 pm Purchase |
2022-01-06 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 1,542,180 10.200% |
120,333![]() (+8.46%) |
Filing History |
2022-01-10 4:49 pm Purchase |
2021-12-31 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 1,421,847 9.400% |
490,097![]() (+52.60%) |
Filing History |
2022-01-03 4:34 pm Purchase |
2021-12-21 | 13G | CytomX Therapeutics, Inc. CTMX |
BIOTECHNOLOGY VALUE FUND L P | 5,803,700 8.900% |
2,884,229![]() (+98.79%) |
Filing History |
2021-12-20 5:23 pm Purchase |
2021-12-10 | 13G | Pyxis Oncology, Inc. PYXS |
BIOTECHNOLOGY VALUE FUND L P | 1,791,351 5.500% |
1,791,351![]() (New Position) |
Filing History |
2021-12-20 4:52 pm Purchase |
2021-12-16 | 13G | Cullinan Oncology, Inc. CGEM |
BIOTECHNOLOGY VALUE FUND L P | 4,394,459 10.100% |
1,787,653![]() (+68.58%) |
Filing History |
2021-12-20 4:51 pm Purchase |
2021-12-09 | 13G | Relmada Therapeutics, Inc. RLMD |
BIOTECHNOLOGY VALUE FUND L P | 1,647,400 5.900% |
1,647,400![]() (New Position) |
Filing History |
2021-12-16 5:16 pm Purchase |
2021-12-14 | 13G | Cidara Therapeutics, Inc. CDTX |
BIOTECHNOLOGY VALUE FUND L P | 343,056 10.300% |
119,982![]() (+53.79%) |
Filing History |
2021-12-02 5:05 pm Purchase |
2021-11-30 | 13D | Olema Pharmaceuticals, Inc. OLMA |
BIOTECHNOLOGY VALUE FUND L P | 7,411,503 18.400% |
750,000![]() (+11.26%) |
Filing History |
2021-11-15 4:58 pm Purchase |
2021-11-03 | 13G | Concert Pharmaceuticals, Inc. CNCE |
BIOTECHNOLOGY VALUE FUND L P | 3,596,757 9.990% |
3,596,757![]() (New Position) |
Filing History |